ARROW EXPLORATION CORP. (AXL) — Research Note
Executive summary
Arrow Exploration is an AIM-listed Canadian junior with all its current production from Colombia — primarily the Tapir block in the Llanos basin (Rio Cravo Este, Carrizales Norte, Alberta Llanos) plus the smaller Oso Pardo and dormant Ombu blocks, with a tail of Alberta gas. Operationally the period covered shows a sharp ramp from 461 boe/d in FY2021 to a Q4-2024 peak of 4,738 boe/d, then a step back to 4,023 boe/d YTD 2025 as water cuts rose, netbacks fell from $50.76/boe (Q3-24) to $35.72/boe (Q3-25), and the company spent heavily ($35.4m YTD-25 capex) without growing production. The single most important valuation question is whether the Tapir block extension is granted — without it, the asset that contains essentially all of Arrow's reserves and production goes away.
Fair value estimate
Methodology: NAV anchored to the company's YE2023 reserve report (last filed in dataset), with haircuts for the 2025 deterioration in netbacks and the unresolved Tapir extension.
- YE2023 2P NPV10 pre-tax: US$280m (≈£218m at ~0.78 GBP/USD)
- YE2023 1P NPV10 pre-tax: US$135m (≈£105m)
- 2025 reality check: realized corporate price down ~16% YTD, opex per boe roughly doubled, capex outpacing production growth. A 25–35% haircut to the 2P NAV is defensible.
Fair value range (per share, pence):
- Low: ~35p (1P NAV-equivalent, heavy haircut for Tapir/cost risk) → mcap ~£100m
- High: ~75p (2P NAV near full credit, assumes Tapir extension granted, opex normalises) → mcap ~£215m
- Mid: ~55p / £155m mcap
Compared to current £62.9m mcap (~22p): absolute upside ~150% to the midpoint, ~60% to the low. The asset base appears materially undervalued if the Tapir extension is granted and Mateguafa Attic / Icaco deliver — both are open questions, which is why I do not anchor at the optimistic end.
Sector context
Confirmed: ICB Energy, oil & gas E&P, small-cap Latin-America-focused junior. Quality is below the average AIM oil-junior peer set on production size, but balance sheet is well above average (no debt, net cash). Closest listed peers:
- GeoPark (NYSE: GPRK) — far larger Colombian focus
- Gran Tierra Energy (TSX/NYSE: GTE) — Colombia/Ecuador mid-cap
- Petrolia Energy / Trillion Energy / Jadestone — small-cap E&P comparators on AIM/TSX-V
Investment thesis
- Producing asset base trades at a steep discount to 2P NAV. YE2023 2P NPV10 pre-tax of US$280m vs current £63m mcap is a >3× gap; even with conservative haircuts the equity looks cheap if Colombia execution continues 2024-04 annual results, 2024-12 reserves filing.
- Fortress balance sheet for a junior. Net cash position, no drawn debt at Q3-25, plus undrawn US$20m crude prepayment facility with an integrated major — meaning the 2026 Icaco exploration well, Mateguafa Attic development, and ongoing Tapir program can be self-funded from cash flow 2025-11 Q3-25 results.
- Multiple near-term catalysts. Mateguafa Attic discovery being delineated (M-5, M-6, M-HZ7), Icaco prospect to be drilled Q1 2026, and Tapir extension decision pending — any positive outcome could re-rate the equity materially 2025-11 Q3-25 results.
Key risks
- Tapir block extension is unresolved and existential. Tapir is essentially the whole company — RCE, CN, Alberta Llanos, Mateguafa, and Icaco all sit on it. Management says "all requirements met," but the Colombian regulator has not signed; if denied or materially restructured, fair value collapses 2025-11 Q3-25 results.
- Water cut and opex deterioration in 2025. Crude opex jumped from $5.91/bbl in Q3-24 to $11.88/bbl in Q3-25 as wells produced more water; corporate netback halved YoY. If water management investments don't pay back as guided, netbacks stay compressed 2025-11 Q3-25 results, 2025-08 Q2-25 results.
- Commodity & country risk. Brent has slid to ~$70 from $80-plus, Colombian fiscal regime is politically volatile (royalty deductibility ruling, presidential rhetoric on hydrocarbons), and the company has $12m of work commitments on the COR-39 block it is trying to cancel (not disclosed but inferred — failure to cancel would crystallise cash outflow).
Operating leverage
Arrow has modest, not strong, operating leverage. Fixed cost base is dominated by G&A (~$10m run-rate, broadly flat) and central depletion; variable costs are royalties (~12% of revenue) plus production opex which has actually been negatively operating-leveraged in 2025 (more wells = more water = higher per-boe lifting cost). Incremental revenue from a new horizontal well at CN or RCE drops at roughly netback economics — recently $35/boe, historically $50/boe. So a 10–20% revenue surprise (say from a successful Mateguafa Attic / Icaco discovery) would plausibly add ~30–50% to operating profit, not multiples. This is commodity-producer operating leverage — meaningful but not the asymmetric long-tail the investor profile is seeking 2025-11 Q3-25 results, segmented data.
Value-trap signals
- Production stagnation despite heavy capex. $35m spent YTD 2025 has held production roughly flat YoY — the capital intensity is materially higher than the 2024 program implied.
- Operating cost deterioration unaddressed for multiple quarters. Water-handling problems have run from Q1 through Q3 2025 with promised infrastructure fixes still in progress.
- Related-party loans to executives and directors of ~$0.7m outstanding at Q3-25 (note 4, trade and other receivables) — small but a governance flag.
- Tapir extension delay is genuinely a structural threat, not a temporary mispricing — if it goes wrong, the discount to NAV is justified.
Earnings vs. expectations
Arrow does not issue formal numerical guidance and is not covered by sell-side consensus in the conventional sense. Comparing reported delivery against management's own indications: 2022–2024 trajectory beat management's prior expectations — production grew from 461 boe/d (FY21) to 1,345 (FY22) to 2,167 (FY23) to 3,542 (FY24), well ahead of any prior pacing. 2025 has materially undershot. Q1-25 production was 14% below Q4-24, water issues escalated through Q2, capex ran ahead of plan, and Q3-25 netback was $35.72/boe vs management's own $50+ baseline. Pattern: strong beats 2022–24, clear miss vs trajectory in 2025.
Conviction
Conviction: 2 (low)
Anchors: (i) the reserve report and netback economics give a credible NAV floor, (ii) the balance sheet is unambiguous (net cash, no debt) so the company is not at financial risk in the next 12 months. Limiters: (i) the Tapir extension is binary and unresolved — a single regulatory event can move fair value 50%+ in either direction, (ii) the 2025 operational deterioration (water cuts, opex inflation) makes the YE2023 reserves report stale, and I do not have a 2025 reserves update in the filings provided, (iii) commodity price assumption is doing a lot of work in any NAV.